CPI-0610, a bromodomain and extraterminal domain protein (bet) inhibitor, in combination with ruxolitinib, in jak-inhibitor-naive myelofibrosis patients: update of manifest phase 2 study

被引:0
作者
Mead, Adam [1 ]
Mascarenhas, John [2 ]
Talpaz, Moshe [3 ]
Patriarca, Andrea [4 ]
Devos, Timothy [5 ,6 ]
Palandri, Francesca [7 ]
Passamonti, Francesco [8 ]
Rampal, Raajit [9 ]
Kremyanskaya, Marina
Scandura, Joseph [10 ]
Somervaille, Tim [11 ]
Wondergem, Marielle [12 ]
Granacher, Nikki [13 ]
Hoffman, Ronald [2 ]
Gupta, Vikas [14 ]
Luptakova, Katarina [15 ]
Wang, Jing [15 ]
Christo, Jessica [15 ]
Colak, Gozde [15 ]
Shao, James [15 ]
Bobba, Suresh [15 ]
Trojer, Patrick [15 ]
Verstovsek, Srdan [16 ]
Harrison, Claire [17 ]
机构
[1] Oxford Univ Hosp NHS Fdn Trust, Oxford, England
[2] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
[3] Univ Michigan, Ann Arbor, MI 48109 USA
[4] Azienda Osped Univ Maggiore della Carita Novara S, Novara, Italy
[5] Univ Hosp Leuven, Leuven, Belgium
[6] Rega Inst, Lab Mol Immunol, Leuven, Belgium
[7] S Orsola Malpighi Bologna Univ Hosp, Inst Hematol L&A Seragnoli, Bologna, Italy
[8] Univ Hosp Osped Circolo, Varese, Italy
[9] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[10] New York Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA
[11] Univ Manchester, Canc Res UK Manchester Inst, Christie Hosp, Manchester, Lancs, England
[12] Acad Ziekenhuis Vrije Univ, Amsterdam, Netherlands
[13] Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium
[14] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada
[15] Constellat Pharmaceut, Cambridge, England
[16] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[17] Guys & St Thomas Hosp, London, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BSH2021-PO
引用
收藏
页码:96 / 96
页数:1
相关论文
empty
未找到相关数据